Connecticut Supreme Court Unanimously Affirms Summary Judgment for Axinn Client
February 10, 2014
Axinn successfully defended a multimillion dollar contract dispute for insurance broker Brown & Brown with a unanimous victory in the Connecticut Supreme Court.
The case related to Brown & Brown’s 2004 purchase of assets from a Connecticut-based insurance broker. Axinn previously won dispositive motions on all issues in the case in the Connecticut Superior Court’s Complex Litigation Docket for Brown & Brown and successfully defended that victory in the Connecticut Appellate Court.
The Connecticut Supreme Court then granted review of whether the Appellate Court correctly determined that Brown & Brown could not hinder performance of a contract through alleged conduct that took place before the contract was signed. The Court’s unanimous decision sided with Brown & Brown on both the procedural and substantive components of that issue, bringing more than five years of litigation to a successful conclusion for Brown & Brown. In the process, the Court provided important guidance on several issues of appellate procedure for Connecticut litigants.
Brown & Brown was represented by an Axinn team that included Mark Alexander, who argued in the Connecticut Supreme Court, and John Tanski, who argued in the Connecticut Appellate Court.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
